More serious but rare safety considerations include pancreatitis (discontinue if suspected), gallbladder disease, potential thyroid C-cell tumors (based on rodent studies), risk of hypoglycemia when used with insulin or sulfonylureas, and potential for acute kidney injury with severe dehydration
Medicines to help with nausea, such as ondansetron, or treatments for constipation or diarrhea may be used when needed
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
By counteracting oxidative stress, it could potentially help minimize the appearance of wrinkles, fine lines, and other age-related skin changes
By prioritizing nutrient-dense foods, portion control, and hydration, you can enhance weight loss outcomes and enjoy numerous health benefits
This guide covers the complete retatrutide dosage escalation schedule, dose-by-dose weight loss outcomes, safety profiles by dose level, and reconstitution protocols for research use